This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Janssen Biotech, Inc., Stichting Vumc. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 433 
2 out of 9 Years Active: 2024
Title: Christie Verkleij: Innovator in Cancer Treatment
Introduction
Christie Verkleij is a prominent inventor based in De Boelelaan, Netherlands. She has made significant contributions to the field of cancer treatment through her innovative methods. With a focus on enhancing the efficacy of T cell redirecting therapeutics, her work is paving the way for advancements in oncology.
Latest Patents
Christie Verkleij holds 2 patents related to her groundbreaking research. Her latest patents include methods of treating cancers and enhancing the efficacy of T cell redirecting therapeutics. These patents disclose novel approaches that could revolutionize cancer therapies and improve patient outcomes.
Career Highlights
Throughout her career, Christie has worked with notable organizations, including Janssen Biotech, Inc. and Stichting Vumc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to impactful research.
Collaborations
Some of her coworkers include Homer Adams and Francois Gaudet. Their collaboration has further enriched her research and development efforts in cancer treatment.
Conclusion
Christie Verkleij's innovative work in cancer treatment exemplifies her dedication to improving therapeutic methods. Her patents and collaborations highlight her significant role in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile